AYTU · Company research
AYTU BioPharma, Inc. (AYTU): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 2.05 | $23,966,409.24 | 4002409.24 | — | — | — | 0.57800523924368126568 | 0.74506199645599527466 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.